DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slipped 2.82% to $143.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.87% to 7,641.16 and Dow Jones Industrial Average falling 1.32% to 52,759.21.
The stock's fall snapped a seven-day winning streak.
Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company achieved on February 11th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 2.21% to $267.37, Pfizer Inc. $(PFE)$ fell 1.59% to $27.79, and Abbott Laboratories $(ABT)$ fell 0.25% to $114.14.
Trading volume (7.2 M) remained 286,153 below its 50-day average volume of 7.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.
Comments